Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/27/2025

Management of Mild Hyponatremia

Assessment and Management

  • The American Association for the Study of Liver Diseases recommends determining the type of hyponatremia based on volume status: hypovolemic, euvolemic, or hypervolemic 1, 2
  • Evaluate for symptoms: mild hyponatremia (126-135 mmol/L) rarely causes significant symptoms, according to the American Association for the Study of Liver Diseases 1, 3
  • Consider the chronicity of hyponatremia, as acute onset (<48 hours) is managed differently than chronic hyponatremia, as suggested by the European Society of Intensive Care Medicine 2
  • For hypovolemic hyponatremia, the American College of Physicians recommends discontinuing diuretics if they're contributing to hyponatremia and providing fluid resuscitation with isotonic saline (0.9% NaCl) 1, 4
  • For euvolemic hyponatremia, the European Society of Endocrinology recommends implementing fluid restriction to 1-1.5 L/day and considering oral sodium supplementation (NaCl 100 mEq three times daily) if needed for persistent hyponatremia 2, 5
  • For hypervolemic hyponatremia, the American Heart Association recommends implementing fluid restriction to 1-1.5 L/day and treating the underlying condition (e.g., heart failure, cirrhosis) 2, 4
  • The American Association for the Study of Liver Diseases suggests considering albumin infusion in patients with cirrhosis 1, 3
  • For asymptomatic patients with sodium of 129 mmol/L, fluid restriction alone is typically sufficient, according to the American Association for the Study of Liver Diseases 1, 3
  • Monitor serum sodium levels but avoid aggressive correction, as recommended by the European Society of Intensive Care Medicine 2
  • Patients with cirrhosis and serum sodium ≤130 mmol/L are at increased risk for developing hepatic encephalopathy, hepatorenal syndrome, and spontaneous bacterial peritonitis, according to the American Association for the Study of Liver Diseases 1, 3
  • For patients with liver disease or malnutrition, use even more conservative correction rates (4-6 mmol/L per day) due to higher risk of osmotic demyelination, as suggested by the European Society of Intensive Care Medicine 2
  • Vasopressin receptor antagonists (vaptans) should be reserved for clinically significant hyponatremia resistant to fluid restriction, according to the European Society of Endocrinology 2
  • For mild hyponatremia (sodium of 129), regular monitoring of serum electrolytes is sufficient, as recommended by the American Association for the Study of Liver Diseases 1, 2
  • If implementing active treatment, monitor serum sodium every 4-6 hours initially, as suggested by the European Society of Intensive Care Medicine 5